Is the low-thalidomide dose MPT regimen beneficial?

Korean J Intern Med. 2011 Dec;26(4):400-2. doi: 10.3904/kjim.2011.26.4.400. Epub 2011 Nov 28.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / therapeutic use*
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Humans
  • Melphalan / administration & dosage
  • Melphalan / therapeutic use*
  • Multiple Myeloma / drug therapy*
  • Prednisone / therapeutic use
  • Thalidomide / administration & dosage
  • Thalidomide / therapeutic use*
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents, Alkylating
  • Thalidomide
  • Melphalan
  • Prednisone